Gouvernance UCB

UCB

BE0003739530

Produits pharmaceutiques

Marché Fermé - Euronext Bruxelles Autres places de cotation 17:55:00 15/07/2026			Après clôture 21:05:19
235,70 ^EUR	+1,38%		235,90	+0,08%

13/07	Antengene reçoit un paiement d'étape de 60 millions de dollars dans le cadre de son accord de licence avec UCB	MT
09/07	Sciences de la vie au Royaume-Uni : le cap des 3 milliards de livres d'investissement franchi	MT

Comité Exécutif: UCB

Dirigeant

Fonctions occupéesDepuis

Jean-Christophe Tellier

67 ans

Chief Executive Officer

01/01/2015

Sandrine Dufour

59 ans

Director of Finance/CFO

01/07/2020

Denelle Waynick

59 ans

General Counsel

01/04/2023

Thomas Debeys

Comptroller/Controller/Auditor

Jean Fleurial

61 ans

Human Resources Officer

01/09/2017

Raf Remijsen

Treasurer

01/03/2016

Xavier Michel

Corporate Secretary

01/06/2013

Antje Witte

Investor Relations Contact

Alistair Henry

59 ans

Chief Tech/Sci/R&D Officer

01/05/2024

Composition du Conseil d'Administration: UCB

Administrateur

ComitésDepuis

Jonathan Peacock

68 ans

Audit Committee Chair

09/03/2023

Dame Davies

75 ans

Compensation Committee Chair	15/03/2024
Governance Committee Chair	15/03/2024
Nominating Committee Chair	15/03/2024
Compensation Committee	01/03/2021
Nominating Committee	01/03/2021

Pierre Gurdjian

65 ans

Compensation Committee
Governance Committee	28/04/2016
Nominating Committee
Finance Committee Chair

Charles-Antoine Janssen

55 ans

Compensation Committee	15/03/2024
Governance Committee	15/03/2024
Nominating Committee	15/03/2024

Nefertiti Greene

55 ans

Compensation Committee	25/04/2024
Governance Committee	25/04/2024
Nominating Committee	25/04/2024

Ulf Arne Wiinberg

68 ans

Compensation Committee	01/07/2017
Governance Committee	15/03/2024
Nominating Committee	15/03/2024

Jean-Christophe Tellier

67 ans

Executive Committee Chair

19/01/2015

Maëlys Castella

60 ans

Audit Committee

01/01/2023

Jonkheer Cédric van Rijckevorsel

56 ans

Audit Committee

15/03/2024

Cyril Janssen

55 ans

Director/Board Member

01/01/2015

Jan Berger

69 ans

Director/Board Member	01/04/2019
Independent Dir/Board Member	01/04/2019

Susan Gasser

71 ans

Director/Board Member	01/01/2021
Independent Dir/Board Member	01/01/2021

Dolca Thomas

56 ans

Director/Board Member	25/04/2024
Independent Dir/Board Member	25/04/2024

Dernières Nominations: UCB

21/04	Bavarian Nordic A/S approuve les nominations au conseil d'administration	CI
30/03	Sai Life Sciences Limited annonce des changements au sein de sa direction	CI
27/03	Kay Davies ne sollicitera pas le renouvellement de son mandat d'administratrice indépendante chez UCB	CI
10/03	H. Lundbeck A/S nomme Markus Kede au poste de Senior Vice President et Chief AI Officer, intégrant le Comité de Direction au 1er juillet 2026	CI
21/01	Ocular Therapeutix, Inc. nomme David W. Robinson au poste de directeur commercial mondial	CI
18/12	Bavarian Nordic AS nomme Anne Louise Eberhard nouvelle présidente du conseil d'administration	CI
25/09/25	Financière de Tubize SA Renforce son Conseil d'Administration	CI

Plus d'Actualités

Anciens Dirigeants et Administrateurs: UCB

Insider

Fonctions occupées

DepuisJusqu'au

Albrecht de Graeve

Director/Board Member	29/04/2010	25/04/2024
Independent Dir/Board Member	29/04/2010	-

Iris Löw-Friedrich

Chief Tech/Sci/R&D Officer

01/03/2008

01/01/2024

Douglas James Gingerella

Comptroller/Controller/Auditor

01/09/2021

Pascale Richetta

Corporate Officer/Principal

15/01/2016

01/02/2020

Bharat Tewarie

Sales & Marketing

01/03/2015

01/02/2020

Anna Richo

General Counsel

01/11/2012

01/01/2019

Fabrice Enderlin

Human Resources Officer	01/03/2008	31/12/2017
Public Communications Contact	-	-

Ismail Kola

Chief Tech/Sci/R&D Officer

01/11/2009

31/12/2017

Harriet Edelman

Director/Board Member	01/01/2012	01/04/2017
Independent Dir/Board Member	01/01/2012	01/04/2017

Viviane Monges

Director/Board Member	01/04/2017	-
Independent Dir/Board Member	01/04/2017	-

Gerhard Mayr

Director/Board Member	01/01/2005	01/01/2017
Independent Dir/Board Member	01/01/2005	01/01/2017

Neil Weir

Corporate Officer/Principal

01/01/2017

Mark McDade

Chief Operating Officer	01/02/2015	01/10/2016
Corporate Officer/Principal	01/04/2008	01/02/2015

Thomas McKillop

Director/Board Member	01/01/2009	28/04/2016
Independent Dir/Board Member	01/01/2009	28/04/2016

Mohammed Khoso Baluch

Corporate Officer/Principal	01/02/2013	01/04/2016
Sales & Marketing	01/01/2008	01/04/2016

Alice Dautry-Varsat

Director/Board Member	01/01/2015	-
Independent Dir/Board Member	01/01/2015	-

Frederic Roch Doliveux

Director/Board Member	15/08/2011	31/12/2014
Chief Executive Officer	15/08/2011	31/12/2014
Director/Board Member	01/06/2017	01/01/2021

Peter John Fellner

Director/Board Member	01/01/2005	08/05/2014
Independent Dir/Board Member	14/09/2010	08/05/2014

Gregory Duncan

Corporate Officer/Principal

01/04/2007

01/02/2013

Karel Boone

Chairman

04/02/2010

30/04/2012

Gaëtan van de Werve

Director/Board Member

05/02/2010

26/04/2012

Thomas Leysen

Director/Board Member	01/01/2009	26/04/2012
Independent Dir/Board Member	20/05/2011	26/04/2012

Alexandre van Damme

Director/Board Member

14/09/2010

15/03/2012

Scott Myers

Corporate Officer/Principal

01/01/2007

01/09/2011

Michèle de Cannart

Corporate Officer/Principal

01/01/2000

01/06/2011

Fabrice Egros

Corporate Officer/Principal

01/09/2009

01/02/2011

Lorenz d'Este

Director/Board Member

22/02/2010

29/04/2010

Patrick Schwarz-Schütte

Director/Board Member

01/04/2009

Armand de Decker

Director/Board Member	01/01/2009	-
Independent Dir/Board Member	16/08/2011	-

Guy Keutgen

Director/Board Member

31/12/2008

Bill Robinson

Chief Operating Officer

31/12/2008

Alan John Blinken

Director/Board Member

31/12/2008

Jean-Louis Vanherweghem

Director/Board Member

31/12/2008

Sarah Howell

Corporate Officer/Principal

01/01/2004

01/07/2008

Nunzio Antonelli

Chief Tech/Sci/R&D Officer	01/06/2008	-
Corporate Officer/Principal	16/09/2010	14/02/2013

Jean-Pierre Kinet

Director/Board Member	01/01/2009	-
Independent Dir/Board Member	16/08/2011	-

Norman J. Ornstein

Director/Board Member	01/01/2008	-
Independent Dir/Board Member	01/01/2008	-

Richard Sachse

Corporate Officer/Principal

01/01/2007

Anthony G. Tebbutt

President

01/09/1996

01/10/2006

Detlef Thielgen

Director of Finance/CFO

01/01/2007

Inge Basteleurs

Director/Board Member	01/06/2011	-
General Counsel	01/06/2011	-
Corporate Secretary	01/06/2011	-

Frank Aranzana

Corporate Officer/Principal

01/01/1999

Georges Jacobs de Hagen

President

31/12/2004

Robert Trainor

General Counsel

05/02/2010

Luc Missorten

Director of Finance/CFO

01/01/2003

Laurent Lenoir

Corporate Officer/Principal

01/01/1991

01/01/2003

Jean-François Prost

Chief Tech/Sci/R&D Officer

01/01/2000

Jean M. Bellin

Corporate Officer/Principal

01/01/1993

01/01/1996

Jean van Rijckevorsel

Director/Board Member

01/01/1992

Piet Vanneste

Corporate Officer/Principal

01/01/1990

Evelyn du Monceau

Director/Board Member	01/01/1984	-
Chairman	-	-

Arnoud de Pret Roose de Calesberg

Director/Board Member

23/03/2011

Pol Vanderhaeghen

Corporate Officer/Principal

01/01/1973

Phee Wah Koh

Corporate Officer/Principal

Karen Stoddart

Corporate Officer/Principal

Nathalie Deldime

Public Communications Contact

Penelope Ward

Corporate Officer/Principal

Grahaem Brown

Corporate Officer/Principal

Arnaud Denis

Public Communications Contact

29/07/2009

Michel Mahy

Corporate Officer/Principal

O'Neill F. D'Cruz

Corporate Officer/Principal

Richard Simpson

Investor Relations Contact	16/08/2011	-
Public Communications Contact	09/02/2010	16/08/2011

Isabelle Ghellynck

Public Communications Contact

Malini Sundaram

Corporate Officer/Principal

Keith Bragman

Director/Board Member	-	-
Corporate Officer/Principal	-	-

Troy Cox

Corporate Officer/Principal

Gregory J. Dennis

Corporate Officer/Principal

Andrew J. McKnight

Chief Tech/Sci/R&D Officer

Iversen Bo

Comptroller/Controller/Auditor

Andre van der Toorn

Treasurer

Guy Wouters

Corporate Officer/Principal

Frank Coenen

Corporate Officer/Principal

Jan Vandendriessche

Chief Tech/Sci/R&D Officer

Michael Tuck-Sherman

Public Communications Contact

10/01/2011

Emmanuel Lacroix

Corporate Officer/Principal

12/03/2013

Jonathan W. Lewis

Corporate Officer/Principal

Gilles Capart

Chief Investment Officer

Donna M. Radzik

Corporate Officer/Principal

Emmanuel Janssen

Founder

18/01/1928

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	20
Femme	7

Dont comité exécutif

Homme	6
Femme	3

Dont Administrateurs

Homme	11
Femme	2

Révisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Non

Controverses sur les droits de l'Homme

Non

Controverses Subventions fiscales

Non

Conforme à la finance Islamique

UCB est une société biopharmaceutique qui se consacre à la recherche et au développement de nouveaux médicaments et de solutions innovantes destinés aux personnes atteintes de maladies graves du système immunitaire ou du système nerveux central.

Employés

9 765

Secteur

Produits pharmaceutiques

Agenda

Publication des résultats - Q2 2026

Plus d'informations sur la société